Hypertension, Cardiology, Primary Health and Patient Care

Blood Pressure is the definitively most important biometric in Medicine and the single most important surrogate measure utilised in cardiovascular outcomes. For over a century, there has been little innovation in the field of blood pressure measurement and still relegated to the current gold standard methods of auscultation & a mercury/aneuroid column and the invasive arterial line remain. But these methods are problematic and prone to enormous errors due to cyclical oscillometric devices and other cuff-based solutions. More recently Ambulatory Blood Pressure Measurement (ABPM) is now accepted as the gold standard for diagnosis of hypertension. But ABPM is less effective as it is still based old-fashioned cuff based oscillometry and is not an efficient solution to broader use and engagement by patients and is not a beat to beat analysis. Recently there has been a shift in consensus around blood pressure measurement and a new fresh call for novel digital solutions that engage with modern-age patients in new user-friendly platforms has emerged. Use of performance measurement in every day settings at home, in the office and even in sports is becoming of more substantial interest – as is the measurement of blood pressure during sleep. The constituencies that are pushing the momentum on this include health care providers and traditional Pharmaceutical and medical device manufacturers, but also now the top 10 digital technology companies and medical insurance companies.  This is truly and exciting moment in the history of blood pressure measurement – where we are seeing a new field of development for the management of blood pressure with new exciting validated digital technologies that are set to replace the previous systems. This session will examine these developments in more detail and include the introduction to the World of the revolutionary Tarilian Laser Technology novel non-invasive BPM technology.